Shares of Futura Medical plc (LON:FUM – Get Free Report) were up 11.1% during mid-day trading on Friday . The stock traded as high as GBX 38 ($0.49) and last traded at GBX 37.23 ($0.48). Approximately 1,577,831 shares were traded during mid-day trading, an increase of 161% from the average daily volume of 604,413 shares. The stock had previously closed at GBX 33.50 ($0.43).
Futura Medical Stock Performance
The firm has a market cap of £116.12 million, a P/E ratio of -3,436.00 and a beta of 1.25. The stock’s 50-day moving average is GBX 34.84 and its 200 day moving average is GBX 36.
Insider Buying and Selling at Futura Medical
In other news, insider James Henry Barder sold 250,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of GBX 41 ($0.53), for a total transaction of £102,500 ($133,082.32). Insiders own 32.14% of the company’s stock.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Read More
- Five stocks we like better than Futura Medical
- How to Calculate Stock Profit
- Texas Roadhouse Stock Steering for New Highs This Year
- What Are the FAANG Stocks and Are They Good Investments?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to Choose Top Rated Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.